Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Bruserud

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Journal of Clinical & Laboratory Immunology|June 1, 1986
The proliferative T-lymphocyte response to streptokinaseO Bruserud, L Sollid, P F Jørgensen
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 22, 1999
Functional differentiation of acute myeloid leukaemia blast cellsC F Bassøe, A Halstensen, O Bruserud
Oncogene|February 12, 2008
Review: genetic models of acute myeloid leukaemiaE McCormack, O Bruserud, B T Gjertsen
Polskie Archiwum Medycyny Wewnetrznej|August 1, 1988
Studies on the HLA association to insulin-dependent diabetes mellitus (IDDM)K E Lundin, O Bruserud, E Thorsby
The Oncologist|December 8, 2000
Induction of differentiation and apoptosis- a possible strategy in the treatment of adult acute myelogenous leukemiaO Bruserud, B T Gjertsen, Ts Huang
Leukemia|March 11, 2005
Animal models of acute myelogenous leukaemia - development, application and future perspectivesE McCormack, O Bruserud, B T Gjertsen
International Journal of Immunopharmacology|July 1, 1992
CD4+ TCR alpha beta+ T-cell clones derived shortly after allogeneic bone marrow transplantation: theophyllamine and verapamil inhibit proliferation of functionally heterogeneous T-cellsO Bruserud, W Hamann, S Patel, et al.
Cytotherapy|September 9, 2005
Autologous transplantation: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2x10(6) CD34+ cells/kgJ F Abrahamsen, T Wentzel-Larsen, O Bruserud
Scandinavian Journal of Immunology|April 1, 1986
The role of the CD8-positive subset of T cells in proliferative responses to soluble antigens. I. Studies of healthy subjects, type 1 diabetics, and coeliac disease patientsL Sollid, O Bruserud, G Gaudernack, et al.
Acta Haematologica|January 13, 2001
The cellular immune system of patients with acute leukemia and severe chemotherapy-induced leukopenia: characterization of T lymphocyte subsets responsive to IL-16 and IL-17O Bruserud, H L von Volkman, E Ulvestad
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Journal of Clinical & Laboratory Immunology|June 1, 1986
The proliferative T-lymphocyte response to streptokinaseO Bruserud, L Sollid, P F Jørgensen
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 22, 1999
Functional differentiation of acute myeloid leukaemia blast cellsC F Bassøe, A Halstensen, O Bruserud
Oncogene|February 12, 2008
Review: genetic models of acute myeloid leukaemiaE McCormack, O Bruserud, B T Gjertsen
Polskie Archiwum Medycyny Wewnetrznej|August 1, 1988
Studies on the HLA association to insulin-dependent diabetes mellitus (IDDM)K E Lundin, O Bruserud, E Thorsby
The Oncologist|December 8, 2000
Induction of differentiation and apoptosis- a possible strategy in the treatment of adult acute myelogenous leukemiaO Bruserud, B T Gjertsen, Ts Huang
Leukemia|March 11, 2005
Animal models of acute myelogenous leukaemia - development, application and future perspectivesE McCormack, O Bruserud, B T Gjertsen
International Journal of Immunopharmacology|July 1, 1992
CD4+ TCR alpha beta+ T-cell clones derived shortly after allogeneic bone marrow transplantation: theophyllamine and verapamil inhibit proliferation of functionally heterogeneous T-cellsO Bruserud, W Hamann, S Patel, et al.
Cytotherapy|September 9, 2005
Autologous transplantation: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2x10(6) CD34+ cells/kgJ F Abrahamsen, T Wentzel-Larsen, O Bruserud
Scandinavian Journal of Immunology|April 1, 1986
The role of the CD8-positive subset of T cells in proliferative responses to soluble antigens. I. Studies of healthy subjects, type 1 diabetics, and coeliac disease patientsL Sollid, O Bruserud, G Gaudernack, et al.
Acta Haematologica|January 13, 2001
The cellular immune system of patients with acute leukemia and severe chemotherapy-induced leukopenia: characterization of T lymphocyte subsets responsive to IL-16 and IL-17O Bruserud, H L von Volkman, E Ulvestad
Pageof 11